ImageneBio (IMA) Equity Average (2020 - 2024)
Historic Equity Average for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $138.5 million.
- ImageneBio's Equity Average fell 1120.13% to $138.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $138.5 million, marking a year-over-year decrease of 1120.13%. This contributed to the annual value of $158.4 million for FY2023, which is 1074.27% down from last year.
- Per ImageneBio's latest filing, its Equity Average stood at $138.5 million for Q3 2024, which was down 1120.13% from $149.1 million recorded in Q2 2024.
- ImageneBio's 5-year Equity Average high stood at $222.0 million for Q2 2021, and its period low was -$89.8 million during Q4 2020.
- In the last 5 years, ImageneBio's Equity Average had a median value of $154.5 million in 2022 and averaged $123.6 million.
- Per our database at Business Quant, ImageneBio's Equity Average surged by 41547.89% in 2021 and then tumbled by 2964.86% in 2023.
- ImageneBio's Equity Average (Quarter) stood at -$89.8 million in 2020, then surged by 328.99% to $205.6 million in 2021, then fell by 25.63% to $152.9 million in 2022, then increased by 6.33% to $162.6 million in 2023, then decreased by 14.77% to $138.5 million in 2024.
- Its last three reported values are $138.5 million in Q3 2024, $149.1 million for Q2 2024, and $162.6 million during Q1 2024.